Clinical characteristics and COVID-19 outcomes in a regional cohort of pediatric patients with rheumatic diseases

Abstract Background This study aimed to assess the baseline characteristics and clinical outcomes of coronavirus disease 2019 (COVID-19) in pediatric patients with rheumatic and musculoskeletal diseases (RMD) and identify the risk factors associated with symptomatic or severe disease defined as hospital admission, intensive care admission or death. Methods An observational longitudinal study was conducted during the first year of the SARS-CoV-2 pandemic (March 2020–March 2021). All pediatric patients attended at the rheumatology outpatient clinics of six tertiary referral hospitals in Madrid, Spain, with a diagnosis of RMD and COVID-19 were included. Main outcomes were symptomatic disease and hospital admission. The covariates were sociodemographic and clinical characteristics and treatment regimens. We ran a multivariable logistic regression model to assess associated factors for outcomes. Results The study population included 77 pediatric patients. Mean age was 11.88 (4.04) years Of these, 30 patients (38.96%) were asymptomatic, 41 (53.25%) had a mild-moderate COVID-19 and 6 patients (7.79%) required hospital admission. The median length of hospital admission was 5 (2–20) days, one patient required intensive care and there were no deaths. Previous comorbidities increased the risk for symptomatic disease and hospital admission. Compared with outpatients, the factor independently associated with hospital admission was previous use of glucocorticoids (OR 3.51; p = 0.00). No statistically significant risk factors for symptomatic COVID-19 were found in the final model. Conclusion No differences in COVID-19 outcomes according to childhood-onset rheumatic disease types were found. Results suggest that associated comorbidities and treatment with glucocorticoids increase the risk of hospital admission.

Download Full-text

Clinical characteristics and COVID-19 outcomes in a regional cohort of pediatric patients with rheumatic diseases

10.1101/2021.05.19.21257450 ◽

2021 ◽

Author(s):

Daniel Clemente ◽

Clara Udaondo ◽

Jaime de Inocencio ◽

Juan Carlos Nieto ◽

Pilar Galan del Rio ◽

...

Keyword(s):

Risk Factors ◽

Hospital Admission ◽

Rheumatic Diseases ◽

Pediatric Patients ◽

Musculoskeletal Diseases ◽

Severe Disease ◽

Tertiary Hospital ◽

Multivariable Logistic Regression Model ◽

Symptomatic Disease ◽

Moderate Disease

Background: This study aimed to assess the baseline characteristics and clinical outcomes of coronavirus disease 2019 (COVID-19) in pediatric patients with rheumatic and musculoskeletal diseases (RMD) and identify the risk factors associated with symptomatic or severe disease defined as hospital admission, intensive care admission or death. Methods: An observational longitudinal study was conducted during the first year of pandemic SARS-CoV-2 (1st March 2020 to 1st March 2021). All pediatric patients attended at the rheumatology outpatient clinic of six tertiary hospital in Madrid, Spain, with a medical diagnosis of RMD and COVID-19 were included. Main outcomes were symptomatic disease and hospital admission. The covariates were sociodemographic, clinical, and treatments. We ran a multivariable logistic regression model to assess risk factors for outcomes. Results: The study population included 77 pediatric patients. Mean age was 11.88 (4.04) years Of these, 30 patients were asymptomatic, 41 had a mild or moderate disease and other 6 patients (7.79%) required hospital admission related to COVID-19. The median length of stay was 5 (2-20) days and there was no death. Previous comorbidities increased the risk for symptomatic disease and hospital admission. Compared with outpatients, the factor independently associated with hospital admission was the use of glucocorticoids (OR 1.08; p=0.00). No statistically significant findings for symptomatic COVID-19 were found in the final model. Conclusion: Our data found no differences in COVID-19 outcomes between children-onset rheumatic diseases. Our results suggest that associated comorbidities and being in treatment with glucocorticoids increase the risk of hospital admission.

Download Full-text

Clinical characteristics associated with COVID-19 severity in California

Journal of Clinical and Translational Science ◽

10.1017/cts.2020.40 ◽

2020 ◽

pp. 1-4 ◽

Cited By ~ 5

Author(s):

Samuel J. S. Rubin ◽

Samuel R. Falkson ◽

Nicholas R. Degner ◽

Catherine Blish

Keyword(s):

Risk Factors ◽

Intensive Care Unit ◽

Acute Respiratory Distress Syndrome ◽

Intensive Care ◽

Clinical Characteristics ◽

Distress Syndrome ◽

Clinical Presentation ◽

Severe Disease ◽

Disease Outcomes ◽

Replicated Data

Abstract Given the rapidly progressing coronavirus disease 2019 (COVID-19) pandemic, this report on a US cohort of 54 COVID-19 patients from Stanford Hospital and data regarding risk factors for severe disease obtained at initial clinical presentation is highly important and immediately clinically relevant. We identified low presenting oxygen saturation as predictive of severe disease outcomes, such as diagnosis of pneumonia, acute respiratory distress syndrome, and admission to the intensive care unit, and also replicated data from China suggesting an association between hypertension and disease severity. Clinicians will benefit by tools to rapidly risk stratify patients at presentation by likelihood of progression to severe disease.

Download Full-text

Disease severity related to VOC dominance in unvaccinated SARS-CoV-2 positive adults without risk factors in Sweden

10.1101/2021.12.23.21268040 ◽

2021 ◽

Author(s):

Erik Wahlstrom ◽

Daniel Bruce ◽

Anna M Bennet-Bark ◽

Sten Walther ◽

Hakan Hanberger ◽

...

Keyword(s):

Risk Factors ◽

Intensive Care Unit ◽

Intensive Care ◽

Hospital Admission ◽

Severe Disease ◽

High Flow ◽

Severe Illness ◽

Economic Factors ◽

Increased Risk ◽

Socio Economic Factors

Although the emerging SARS-CoV-2 variants of concern (VOC) have shown increasing transmissibility, their role for causing severe disease has not been fully clarified. Here, we studied changes in rates of hospitalisation and severe illness (subjection to high-flow nasal oxygen or admission to an intensive care unit during hospital stay) among all (n=685 891) unvaccinated SARS-CoV-2 positive adults without risk factors in Sweden from November 2020 to September 2021. After adjustment for age, sex, and socio-economic factors, and with November 2020 (non-VOC period) as reference, the odds ratios (OR) for hospitalisation were 1.6-1.7 in March-May 2021 (Alpha VOC dominance) and 2.4-3.0 in June-September 2021 (Delta VOC dominance), and the ORs for severe illness were 1.8-2.1 in March-May 2021 and 3.1-4.7 in June-September 2021. This study shows that unvaccinated adults without risk factors, have had a gradually increased risk for hospital admission and severe illness when infected with the Alpha and Delta VOCs, respectively.

Download Full-text

Designing a bed-side system for predicting length of stay in a neonatal intensive care unit

Scientific Reports ◽

10.1038/s41598-021-82957-z ◽

2021 ◽

Vol 11 (1) ◽

Author(s):

Harpreet Singh ◽

Su Jin Cho ◽

Shubham Gupta ◽

Ravneet Kaur ◽

S. Sunidhi ◽

...

Keyword(s):

Risk Factors ◽

Intensive Care ◽

Length Of Stay ◽

Neonatal Intensive Care ◽

Financial Burden ◽

Significant Risk ◽

Model Performance ◽

Significant Risk Factor ◽

Validation Dataset ◽

Patient Records

AbstractIncreased length of stay (LOS) in intensive care units is directly associated with the financial burden, anxiety, and increased mortality risks. In the current study, we have incorporated the association of day-to-day nutrition and medication data of the patient during its stay in hospital with its predicted LOS. To demonstrate the same, we developed a model to predict the LOS using risk factors (a) perinatal and antenatal details, (b) deviation of nutrition and medication dosage from guidelines, and (c) clinical diagnoses encountered during NICU stay. Data of 836 patient records (12 months) from two NICU sites were used and validated on 211 patient records (4 months). A bedside user interface integrated with EMR has been designed to display the model performance results on the validation dataset. The study shows that each gestation age group of patients has unique and independent risk factors associated with the LOS. The gestation is a significant risk factor for neonates < 34 weeks, nutrition deviation for < 32 weeks, and clinical diagnosis (sepsis) for ≥ 32 weeks. Patients on medications had considerable extra LOS for ≥ 32 weeks’ gestation. The presented LOS model is tailored for each patient, and deviations from the recommended nutrition and medication guidelines were significantly associated with the predicted LOS.

Download Full-text

Clinical Characteristics of Human Monkeypox, and Risk Factors for Severe Disease

Clinical Infectious Diseases ◽

10.1086/498115 ◽

2005 ◽

Vol 41 (12) ◽

pp. 1742-1751 ◽

Cited By ~ 64

Author(s):

Gregory D. Huhn ◽

Audrey M. Bauer ◽

Krista Yorita ◽

Mary Beth Graham ◽

James Sejvar ◽

...

Keyword(s):

Risk Factors ◽

Clinical Characteristics ◽

Severe Disease

Download Full-text

Analysis of diagnostic criteria for ventilator-associated pneumonia: a cohort study

Revista Brasileira de Enfermagem ◽

10.1590/0034-7167-2019-0653 ◽

2021 ◽

Vol 74 (6) ◽

Author(s):

Caroline Gonçalves Pustiglione Campos ◽

Aline Pacheco ◽

Maria Dagmar da Rocha Gaspar ◽

Guilherme Arcaro ◽

Péricles Martim Reche ◽

...

Keyword(s):

Risk Factors ◽

Intensive Care Unit ◽

Mechanical Ventilation ◽

Cohort Study ◽

Intensive Care ◽

Diagnostic Criteria ◽

Statistical Tests ◽

Significant Risk ◽

Diagnostic Methods ◽

Ventilator Associated Pneumonia

ABSTRACT Objectives: to analyze the diagnostic criteria for ventilator-associated pneumonia recommended by the Brazilian Health Regulatory Agency and the National Healthcare Safety Network/Centers for Disease Control and Prevention, as well as its risk factors. Methods: retrospective cohort study carried out in an intensive care unit throughout 12 months, in 2017. Analyses included chi-square, simple linear regression, and Kappa statistical tests and were conducted using Stata 12 software. Results: the sample was 543 patients who were in the intensive care unit and under mechanical ventilation, of whom 330 (60.9%) were men and 213 (39.1%) were women. Variables such as gender, age, time under mechanical ventilation, and oral hygiene proved to be significant risk factors for the development of ventilator-associated pneumonia. Conclusions: patients submitted to mechanical ventilation need to be constantly evaluated so the used diagnostic methods can be accurate and applied in an objective and standardized way in Brazilian hospitals.

Download Full-text

Vancomycin-induced nephrotoxicity in non-intensive care unit pediatric patients

Scientific Reports ◽

10.1038/s41598-021-00214-9 ◽

2021 ◽

Vol 11 (1) ◽

Author(s):

Shinhyeung Kwak ◽

Jeong Yeon Kim ◽

Heeyeon Cho

Keyword(s):

Risk Factors ◽

Intensive Care Unit ◽

Intensive Care ◽

Pediatric Patients ◽

Trough Level ◽

Medical Center ◽

Kidney Injury ◽

Maximum Serum ◽

Serum Trough ◽

Youden’S Index

AbstractPrevious data suggested several risk factors for vancomycin-induced nephrotoxicity (VIN), including higher daily dose, long-term use, underlying renal disease, intensive care unit (ICU) admission, and concomitant use of nephrotoxic medications. We conducted this study to investigate the prevalence and risk factors of VIN and to estimate the cut-off serum trough level for predicting acute kidney injury (AKI) in non-ICU pediatric patients. This was a retrospective, observational, single-center study at Samsung Medical Center tertiary hospital, located in Seoul, South Korea. We reviewed the medical records of non-ICU pediatric patients, under 19 years of age with no evidence of previous renal insufficiency, who received vancomycin for more than 48 h between January 2009 and December 2018. The clinical characteristics were compared between patients with AKI and those without to identify the risk factors associated with VIN, and the cut-off value of serum trough level to predict the occurrence of VIN was calculated by the Youden’s index. Among 476 cases, 22 patients (4.62%) developed AKI. The Youden’s index indicated that a maximum serum trough level of vancomycin above 24.35 μg/mL predicted VIN. In multivariate analysis, longer hospital stay, concomitant use of piperacillin-tazobactam and serum trough level of vancomycin above 24.35 μg/mL were associated independently with VIN. Our findings suggest that concomitant use of nephrotoxic medication and higher serum trough level of vancomycin might be associated with the risk of VIN. This study suggests that measuring serum trough level of vancomycin can help clinicians prevent VIN in pediatric patients.

Download Full-text

Risk factors for intensive care admission in children with severe acute asthma in the Netherlands: a prospective multicentre study

ERJ Open Research ◽

10.1183/23120541.00126-2020 ◽

2020 ◽

Vol 6 (3) ◽

pp. 00126-2020 ◽

Cited By ~ 1

Author(s):

Shelley A. Boeschoten ◽

Annemie L. Boehmer ◽

Peter J. Merkus ◽

Joost van Rosmalen ◽

Johan C. de Jongste ◽

...

Keyword(s):

Risk Factors ◽

Intensive Care ◽

The Netherlands ◽

Multicentre Study ◽

Tobacco Smoke ◽

Acute Asthma ◽

Significant Risk ◽

General Ward ◽

Tobacco Smoke Exposure ◽

Severe Acute Asthma

RationaleSevere acute asthma (SAA) can be fatal, but is often preventable. We previously observed in a retrospective cohort study, a three-fold increase in SAA paediatric intensive care (PICU) admissions between 2003 and 2013 in the Netherlands, with a significant increase during those years of numbers of children without treatment of inhaled corticosteroids (ICS).ObjectivesTo determine whether steroid-naïve children are at higher risk of PICU admission among those hospitalised for SAA. Furthermore, we included the secondary risk factors tobacco smoke exposure, allergic sensitisation, previous admissions and viral infections.MethodsA prospective, nationwide multicentre study of children with SAA (2–18 years) admitted to all Dutch PICUs and four general wards between 2016 and 2018. Potential risk factors for PICU admission were assessed using logistic regression analyses.Measurements and main results110 PICU and 111 general ward patients were included. The proportion of steroid-naïve children did not differ significantly between PICU and ward patients. PICU children were significantly older and more exposed to tobacco smoke, with symptoms >1 week prior to admission. Viral susceptibility was not a significant risk factor for PICU admission.ConclusionsChildren with SAA admitted to a PICU were comparable to those admitted to a general ward with respect to ICS treatment prior to admission. Preventable risk factors for PICU admission were >7 days of symptoms without adjustment of therapy and exposure to tobacco smoke. Physicians who treat children with asthma must be aware of these risk factors.

Download Full-text